Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Cytori Therapeutics to Webcast Third Quarter Financial Results on November 9, 2009


Print article Print article
© Business Wire 2009
2009-11-02 13:23:02 -

Cytori Therapeutics Inc. (NASDAQ: CYTX) will release and host a webcast to discuss its third quarter financial results on Monday, November 9, 2009 at 10:30 AM Eastern Time. The webcast will be available both live and by replay two hours after the call on the Company’s website, under “Webcasts” on the Investor Relations page ( ir.cytoritx.com : ).

Prior to the webcast at approximately 7:00 AM Eastern Time on November 9, Cytori will post a shareholder letter to its Investor Relations homepage, which will review Cytori’s third quarter performance, provide an update on commercialization activities and discuss recent developments.

A telephone replay of the conference call webcast will be available through November 16, 2009 and can be accessed by dialing +1

800-406-7325 (Passcode: 4178319).


About Cytori

Cytori is committed to providing patients and physicians around the world with medical technologies, which harness the potential of adult stem and regenerative cells from adipose tissue. With the introduction of a family of medical devices, we have made a patient's own clinical grade stem and regenerative cells available to them at the point-of-care. The Celution ® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets, while we seek regulatory clearance for it in the United States. Our StemSource ® product line is sold globally for cell banking and research applications.


Cytori Therapeutics Inc.Tom Baker, 858-875-5258 tbaker@cytoritx.com : mailto:tbaker@cytoritx.com


Author:
Hossam Abdel-Kader
e-mail
Web: www.pr-inside.com/
Phone: +43 1 9582319

Disclaimer: (c) 2012 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser